Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.20.2
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning of the period at Sep. 30, 2018 $ 159,815 $ 35,517,491 $ (34,317,478) $ 1,359,828
Balance at the beginning of the period (in shares) at Sep. 30, 2018 159,815,013      
Net loss $ 0 0 (3,719,437) (3,719,437)
Issuance of common stock and warrants, net of financing costs $ 8,615 1,083,272 0 1,091,887
Issuance of common stock and warrants, net of financing costs (in shares) 8,615,384      
Shares issued for the exercise of stock options - cashless $ 477 (477) 0 0
Shares issued for the exercise of stock options - cashless (in shares) 477,269      
Shares issued for the exercise of stock options $ 88 32,312 0 32,400
Shares issued for the exercise of stock options (in shares) 87,567      
Issuance of restricted stock $ 3,517 (3,517) 0 0
Issuance of restricted stock (in shares) 3,517,000      
Issuance of restricted stock for services $ 50 21,450 0 21,500
Issuance of restricted stock for services (in shares) 50,000      
Stock based compensation expense $ 0 1,042,285 0 1,042,285
Balance at the ending of the period at Jun. 30, 2019 $ 172,562 37,692,816 (38,036,915) (171,537)
Balance at the ending of the period (in shares) at Jun. 30, 2019 172,562,233      
Balance at the beginning of the period at Mar. 31, 2019 $ 163,947 36,382,873 (36,747,753) (200,933)
Balance at the beginning of the period (in shares) at Mar. 31, 2019 163,946,849      
Net loss $ 0 0 (1,289,162) (1,289,162)
Issuance of common stock and warrants, net of financing costs $ 8,615 1,083,272 0 1,091,887
Issuance of common stock and warrants, net of financing costs (in shares) 8,615,384      
Stock based compensation expense $ 0 226,671 0 226,671
Balance at the ending of the period at Jun. 30, 2019 $ 172,562 37,692,816 (38,036,915) (171,537)
Balance at the ending of the period (in shares) at Jun. 30, 2019 172,562,233      
Balance at the beginning of the period at Sep. 30, 2019 $ 172,612 37,885,151 (38,865,060) $ (807,297)
Balance at the beginning of the period (in shares) at Sep. 30, 2019 172,612,233     173,577,233
Net loss $ 0 0 (3,296,005) $ (3,296,005)
Issuance of common stock and warrants, net of financing costs $ 14,286 2,152,876 0 2,167,162
Issuance of common stock and warrants, net of financing costs (in shares) 14,285,714      
Shares issued for the exercise of warrants $ 5,182 927,546 0 932,728
Shares issued for the exercise of warrants(in shares) 5,181,819      
Stock based compensation expense $ 0 680,231 0 680,231
Balance at the ending of the period at Jun. 30, 2020 $ 192,080 41,645,804 (42,161,065) $ (323,181)
Balance at the ending of the period (in shares) at Jun. 30, 2020 192,079,766     195,590,220
Balance at the beginning of the period at Mar. 31, 2020 $ 186,898 40,534,282 (41,256,698) $ (535,518)
Balance at the beginning of the period (in shares) at Mar. 31, 2020 186,897,947      
Net loss $ 0 $ 0 $ (904,367) $ (904,367)
Shares issued for the exercise of warrants $ 5,181,819      
Shares issued for the exercise of warrants(in shares) 5,182 927,546 0 932,728
Stock based compensation expense $ 0 $ 183,976 $ 0 $ 183,976
Balance at the ending of the period at Jun. 30, 2020 $ 192,080 $ 41,645,804 $ (42,161,065) $ (323,181)
Balance at the ending of the period (in shares) at Jun. 30, 2020 192,079,766     195,590,220